Streetbeat News

Stock Prices

ACI

Albertsons Companies (NYSE:ACI) announced a quarterly dividend of 12 cents per share, with the ex-dividend date set for Thursday. Shareholders owning the stock by the end of Wednesday are eligible for the dividend, to be paid on February 09, 2024. The stock is expected to open 12 cents lower on the ex-dividend date.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

CSWI

CSW Industrials (NASDAQ:CSWI) announced a quarterly dividend of 19 cents per share, with the ex-dividend date set for Thursday. Shareholders owning the stock by the end of Wednesday are eligible for the dividend, to be paid on February 09, 2024. The stock is expected to open 19 cents lower on the ex-dividend date.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

UNM

Unum Group (NYSE:UNM) announced a quarterly dividend of 36.5 cents per share, with the ex-dividend date set for Thursday. Shareholders owning the stock by the end of Wednesday are eligible for the dividend, to be paid on February 16, 2024. The stock is expected to open 36.5 cents lower on the ex-dividend date.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

SKM

TEO

XNET

Benzinga Insights has identified five value stocks in the communication services sector based on low P/E multiples, indicating potential undervaluation. The stocks include KT with a P/E of 7.21, Weibo with a P/E of 4.8, SK Telecom Co with a P/E of 9.76, Xunlei with a P/E of 5.87, and Telecom Argentina with a P/E of 9.83. Each company has shown an increase in earnings per share in their recent quarterly reports, suggesting improved financial performance.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

FSP

Franklin Street Props (AMEX:FSP) announced a quarterly dividend of 1 cent per share, with the ex-dividend date being Thursday. Shareholders owning the stock by the end of Wednesday are eligible for the dividend, which will be paid on February 15, 2024. The stock is expected to open 1 cent lower on the ex-dividend date.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

CVGW

Calavo Growers (NASDAQ:CVGW) announced a quarterly dividend of 10 cents per share, with Wednesday being the last day for investors to be eligible for the dividend. The stock will go ex-dividend on Thursday, indicating an expected opening price reduction by the dividend amount. The dividend is scheduled to be paid on January 31, 2024.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

OVBC

Ohio Valley Banc (NASDAQ:OVBC) announced a quarterly dividend of 22 cents per share, with the ex-dividend date set for Thursday. Shareholders owning the stock by the end of Wednesday are eligible for the payout, which will be distributed on February 10, 2024. The stock is expected to open 22 cents lower on the ex-dividend date.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

UNB

Union Bankshares (NASDAQ:UNB) announced a quarterly dividend of 36 cents per share, with the ex-dividend date set for Thursday. Shareholders owning the stock by the end of Wednesday are eligible for the dividend, which will be paid on February 01, 2024. The stock is expected to open 36 cents lower on the ex-dividend date.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:45 pm

AGRX

PALI

SPOK

XCUR

ZYME

Benzinga Insights identifies five healthcare sector value stocks with low P/E ratios, suggesting they may be undervalued: Exicure (XCUR), Spok Holdings (SPOK), Palisade Bio (PALI), Zymeworks (ZYME), and Agile Therapeutics (AGRX). The article provides recent earnings per share (EPS) data for these companies, noting changes from previous quarters.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 2:44 pm

CHRS

SDZNY

SDZXF

Coherus BioSciences Inc (NASDAQ:CHRS) is trading higher after announcing the sale of its Cimerli ophthalmology franchise to Sandoz Group AG for $170 million plus inventory costs. This move is part of Coherus' strategy to focus on its core oncology business, which includes the Udenyca franchise and Loqtorzi, a PD-1 inhibitor. The deal is expected to close in the first half of 2024, and the proceeds will be used to pay down debt and reduce overhead costs. CHRS shares rose 13.7% on the news.

Portfolio Pulse from Vandana Singh

January 22, 2024 | 2:41 pm